A new study found that injury rates among transgender women are significantly higher than injuries among cisgender women, based on radiological imaging.
Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value bearer shares at an issue price of EUR 8 per share – Biotech Investments
Marinomed Biotech AG / Key word(s): Corporate Action/Capital Increase Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value